Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching AU Mao, Yan-Ping
Results: 79
1
2
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 3, p. 203, doi. 10.3322/caac.21881
- By:
- Publication type:
- Article
3
Analysis of the Stability and Degradation Products of Triptolide.
- Published in:
- Journal of Pharmacy & Pharmacology, 2000, v. 52, n. 1, p. 3, doi. 10.1211/0022357001773625
- By:
- Publication type:
- Article
4
Evaluation of inter-fraction and intra-fraction errors during volumetric modulated arc therapy in nasopharyngeal carcinoma patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
5
Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization.
- Published in:
- 2022
- By:
- Publication type:
- journal article
6
Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events.
- Published in:
- 2021
- By:
- Publication type:
- journal article
7
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
- Published in:
- 2021
- By:
- Publication type:
- Letter
8
Salidroside protects PC-12 cells against amyloid β-induced apoptosis by activation of the ERK1/2 and AKT signaling pathways.
- Published in:
- International Journal of Molecular Medicine, 2019, v. 43, n. 4, p. 1769
- By:
- Publication type:
- Article
9
Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study.
- Published in:
- Radiation Oncology, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13014-022-02095-2
- By:
- Publication type:
- Article
10
Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
11
Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0161878
- By:
- Publication type:
- Article
12
Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
- Published in:
- Head & Neck, 2017, v. 39, n. 3, p. 492, doi. 10.1002/hed.24631
- By:
- Publication type:
- Article
13
Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.
- Published in:
- Head & Neck, 2014, v. 36, n. 4, p. 468, doi. 10.1002/hed.23314
- By:
- Publication type:
- Article
14
Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value.
- Published in:
- Head & Neck, 2011, v. 33, n. 9, p. 1309, doi. 10.1002/hed.21606
- By:
- Publication type:
- Article
15
Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study.
- Published in:
- Cancer Cell International, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12935-022-02748-y
- By:
- Publication type:
- Article
16
Evolving landscape and academic attitudes toward the controversies of global immuno‐oncology trials.
- Published in:
- International Journal of Cancer, 2021, v. 149, n. 1, p. 108, doi. 10.1002/ijc.33503
- By:
- Publication type:
- Article
17
Insights into the ecological roles and evolution of methyl-coenzyme M reductase-containing hot spring Archaea.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12574-y
- By:
- Publication type:
- Article
18
Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3540, doi. 10.1002/cncr.30775
- By:
- Publication type:
- Article
19
Tumor response to neoadjuvant chemotherapy predicts long-term survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: A secondary analysis of a randomized phase 3 clinical trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
20
Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: Analysis of 1301 patients from an endemic area in China.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 1, p. 68, doi. 10.1002/cncr.28377
- By:
- Publication type:
- Article
21
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 12, p. 2230, doi. 10.1002/cncr.28049
- By:
- Publication type:
- Article
22
Prognostic value of nutritional risk screening 2002 scale in nasopharyngeal carcinoma: A large‐scale cohort study.
- Published in:
- Cancer Science, 2018, v. 109, n. 6, p. 1909, doi. 10.1111/cas.13603
- By:
- Publication type:
- Article
23
Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
- Published in:
- Cancer Science, 2018, v. 109, n. 5, p. 1609, doi. 10.1111/cas.13589
- By:
- Publication type:
- Article
24
Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy.
- Published in:
- Cancer Science, 2018, v. 109, n. 3, p. 751, doi. 10.1111/cas.13474
- By:
- Publication type:
- Article
25
Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
- Published in:
- Cancer Science, 2017, v. 108, n. 6, p. 1253, doi. 10.1111/cas.13250
- By:
- Publication type:
- Article
26
An immune‐related seven‐lncRNA signature for head and neck squamous cell carcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 7, p. 2268, doi. 10.1002/cam4.3756
- By:
- Publication type:
- Article
27
Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 1, p. 143, doi. 10.1002/cam4.3580
- By:
- Publication type:
- Article
28
Prognostic value of MRI‐determined cervical lymph node size in nasopharyngeal carcinoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 19, p. 7100, doi. 10.1002/cam4.3392
- By:
- Publication type:
- Article
29
Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6887, doi. 10.1002/cam4.2574
- By:
- Publication type:
- Article
30
The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity‐modulated radiotherapy era.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 5, p. 2213, doi. 10.1002/cam4.2131
- By:
- Publication type:
- Article
31
Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 12, p. 5988, doi. 10.1002/cam4.1858
- By:
- Publication type:
- Article
32
Impact of marital status at diagnosis on survival and its change over time between 1973 and 2012 in patients with nasopharyngeal carcinoma: a propensity score-matched analysis.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 3040, doi. 10.1002/cam4.1232
- By:
- Publication type:
- Article
33
Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2822, doi. 10.1002/cam4.1233
- By:
- Publication type:
- Article
34
Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
- Published in:
- European Radiology, 2024, v. 34, n. 10, p. 6831, doi. 10.1007/s00330-024-10678-8
- By:
- Publication type:
- Article
35
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
- Published in:
- 2020
- By:
- Publication type:
- journal article
36
Refining the Role of Lymph Node Biopsy in Survival for Patients with Nasopharyngeal Carcinoma: Population-Based Study from the Surveillance Epidemiology and End-Results Registry.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 9, p. 2580, doi. 10.1245/s10434-017-5966-4
- By:
- Publication type:
- Article
37
Radiotherapy interruption due to holidays adversely affects the survival of patients with nasopharyngeal carcinoma: a joint analysis based on large-scale retrospective data and clinical trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
38
Disparities in positive results and dissemination of randomized controlled trials in immuno-oncology.
- Published in:
- International Reviews of Immunology, 2023, v. 42, n. 2, p. 91, doi. 10.1080/08830185.2022.2088744
- By:
- Publication type:
- Article
39
Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01343
- By:
- Publication type:
- Article
40
Epstein-Barr virus microRNA BART10-3p promotes dedifferentiation and proliferation of nasopharyngeal carcinoma by targeting ALK7.
- Published in:
- Experimental Biology & Medicine, 2021, v. 246, n. 24, p. 2618, doi. 10.1177/15353702211037261
- By:
- Publication type:
- Article
41
Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.
- Published in:
- Cancer Communications, 2021, v. 41, n. 1, p. 37, doi. 10.1002/cac2.12113
- By:
- Publication type:
- Article
42
Based on network pharmacology and molecular docking technology to explore the mechanism of Panax notoginseng in the treatment of membranous nephropathy.
- Published in:
- Journal of Hainan Medical University, 2023, v. 29, n. 19, p. 36
- By:
- Publication type:
- Article
43
The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 18, p. 3437, doi. 10.1002/cam4.4705
- By:
- Publication type:
- Article
44
The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.
- Published in:
- Scientific Reports, 2016, p. 24835, doi. 10.1038/srep24835
- By:
- Publication type:
- Article
45
The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.
- Published in:
- Scientific Reports, 2016, p. 24332, doi. 10.1038/srep24332
- By:
- Publication type:
- Article
46
Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy.
- Published in:
- Scientific Reports, 2016, p. 22000, doi. 10.1038/srep22000
- By:
- Publication type:
- Article
47
Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy.
- Published in:
- Scientific Reports, 2016, p. 22200, doi. 10.1038/srep22200
- By:
- Publication type:
- Article
48
Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
- Published in:
- Scientific Reports, 2016, p. 22326, doi. 10.1038/srep22326
- By:
- Publication type:
- Article
49
Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.
- Published in:
- Scientific Reports, 2015, p. 16664, doi. 10.1038/srep16664
- By:
- Publication type:
- Article
50
Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
- Published in:
- Scientific Reports, 2015, p. 13919, doi. 10.1038/srep13919
- By:
- Publication type:
- Article